Rubric Capital Management (New York)’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.38M Hold
1,192,191
0.02% 61
2025
Q1
$1.1M Hold
1,192,191
0.02% 65
2024
Q4
$1.03M Hold
1,192,191
0.01% 66
2024
Q3
$1.98M Hold
1,192,191
0.03% 60
2024
Q2
$1.92M Hold
1,192,191
0.05% 64
2024
Q1
$2.73M Hold
1,192,191
0.08% 65
2023
Q4
$2.68M Hold
1,192,191
0.06% 54
2023
Q3
$3.6M Hold
1,192,191
0.14% 56
2023
Q2
$4.91M Hold
1,192,191
0.21% 55
2023
Q1
$4.47M Sell
1,192,191
-565,000
-32% -$2.12M 0.12% 62
2022
Q4
$9.82M Buy
1,757,191
+600,238
+52% +$3.36M 0.43% 56
2022
Q3
$7.68M Buy
1,156,953
+365,122
+46% +$2.42M 0.39% 54
2022
Q2
$7.88M Buy
791,831
+684,945
+641% +$6.82M 0.41% 49
2022
Q1
$2.03M Hold
106,886
0.07% 67
2021
Q4
$1.9M Hold
106,886
0.09% 63
2021
Q3
$3.96M Buy
106,886
+51,000
+91% +$1.89M 0.11% 50
2021
Q2
$3.33M Hold
55,886
0.21% 51
2021
Q1
$3.74M Sell
55,886
-34,526
-38% -$2.31M 0.22% 56
2020
Q4
$5.47M Sell
90,412
-188,239
-68% -$11.4M 0.4% 47
2020
Q3
$22M Buy
278,651
+92,946
+50% +$7.34M 2.05% 22
2020
Q2
$11.6M Sell
185,705
-6,532
-3% -$408K 1.34% 32
2020
Q1
$10.2M Sell
192,237
-28,027
-13% -$1.49M 1.61% 24
2019
Q4
$26.7M Buy
220,264
+82,653
+60% +$10M 3.01% 15
2019
Q3
$25M Buy
137,611
+2,760
+2% +$501K 2.29% 15
2019
Q2
$17.5M Buy
134,851
+41,032
+44% +$5.33M 1.38% 25
2019
Q1
$22.8M Buy
93,819
+62,914
+204% +$15.3M 2.13% 22
2018
Q4
$5.89M Buy
+30,905
New +$5.89M 0.73% 36